Curaleaf Holdings Statistics
Total Valuation
TSX:CURA has a market cap or net worth of CAD 2.90 billion. The enterprise value is 4.29 billion.
| Market Cap | 2.90B |
| Enterprise Value | 4.29B |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CURA has 772.11 million shares outstanding. The number of shares has increased by 2.13% in one year.
| Current Share Class | 678.14M |
| Shares Outstanding | 772.11M |
| Shares Change (YoY) | +2.13% |
| Shares Change (QoQ) | +1.66% |
| Owned by Insiders (%) | 18.55% |
| Owned by Institutions (%) | 3.11% |
| Float | 622.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.66 |
| PB Ratio | 2.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 42.79 |
| P/OCF Ratio | 15.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.59, with an EV/FCF ratio of 63.25.
| EV / Earnings | -11.22 |
| EV / Sales | 2.45 |
| EV / EBITDA | 10.59 |
| EV / EBIT | 284.47 |
| EV / FCF | 63.25 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.13.
| Current Ratio | 1.47 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | 3.55 |
| Debt / FCF | 21.23 |
| Interest Coverage | 0.11 |
Financial Efficiency
Return on equity (ROE) is -21.69% and return on invested capital (ROIC) is 0.33%.
| Return on Equity (ROE) | -21.69% |
| Return on Assets (ROA) | 0.23% |
| Return on Invested Capital (ROIC) | 0.33% |
| Return on Capital Employed (ROCE) | 0.42% |
| Revenue Per Employee | 317,825 |
| Profits Per Employee | -69,288 |
| Employee Count | 5,519 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, TSX:CURA has paid 130.04 million in taxes.
| Income Tax | 130.04M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.56% in the last 52 weeks. The beta is 1.56, so TSX:CURA's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -7.56% |
| 50-Day Moving Average | 4.01 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 44.71 |
| Average Volume (20 Days) | 572,600 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CURA had revenue of CAD 1.75 billion and -382.40 million in losses. Loss per share was -0.51.
| Revenue | 1.75B |
| Gross Profit | 853.24M |
| Operating Income | 15.09M |
| Pretax Income | -172.04M |
| Net Income | -382.40M |
| EBITDA | 326.84M |
| EBIT | 15.09M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 139.48 million in cash and 1.44 billion in debt, giving a net cash position of -1.30 billion or -1.69 per share.
| Cash & Cash Equivalents | 139.48M |
| Total Debt | 1.44B |
| Net Cash | -1.30B |
| Net Cash Per Share | -1.69 |
| Equity (Book Value) | 1.28B |
| Book Value Per Share | 1.55 |
| Working Capital | 187.10M |
Cash Flow
In the last 12 months, operating cash flow was 186.09 million and capital expenditures -118.24 million, giving a free cash flow of 67.85 million.
| Operating Cash Flow | 186.09M |
| Capital Expenditures | -118.24M |
| Free Cash Flow | 67.85M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 48.64%, with operating and profit margins of 0.86% and -18.07%.
| Gross Margin | 48.64% |
| Operating Margin | 0.86% |
| Pretax Margin | -9.81% |
| Profit Margin | -18.07% |
| EBITDA Margin | 18.63% |
| EBIT Margin | 0.86% |
| FCF Margin | 3.87% |
Dividends & Yields
TSX:CURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.13% |
| Shareholder Yield | -2.13% |
| Earnings Yield | -13.17% |
| FCF Yield | 2.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSX:CURA has an Altman Z-Score of 0.25 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.25 |
| Piotroski F-Score | 6 |